(Q43762952)

26 November 2017

Mechanisms of insulin resistance in cystic fibrosis (English)

1 reference

26 November 2017

0 references

1 reference

1 reference

Hardin DS

1

1 reference

26 November 2017

Leblanc A

series ordinal

2

1 reference

26 November 2017

Marshall G

series ordinal

3

1 reference

26 November 2017

Seilheimer DK

series ordinal

4

1 reference

26 November 2017

1 November 2001

1 reference

American Journal of Physiology - Endocrinology and Metabolism

26 November 2017

1 reference

26 November 2017

281

1 reference

26 November 2017

5

1 reference

26 November 2017

E1022-8

1 reference

Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis.

26 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Molecular biology of mammalian glucose transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Cystic fibrosis transmembrane conductance regulator activation stimulates endosome fusion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Inflammatory cytokines in cystic fibrosis lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Intracellular targeting of the insulin-regulatable glucose transporter (GLUT4) is isoform specific and independent of cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Insulin resistance is associated with decreased clinical status in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Identification of the cystic fibrosis gene: genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Insulin induces the translocation of GLUT4 from a unique intracellular organelle to transverse tubules in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Pancreatic endocrine function in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Insulin sensitivity in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Vesicle targeting and ion secretion in epithelial cells: implications for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Mechanism of free fatty acid-induced insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Measuring clinical status in cystic fibrosis: internal validity and reliability of a modified NIH score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

Severity, duration, and mechanisms of insulin resistance during acute infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.5.E1022

10.1152/AJPENDO.2001.281.5.E1022

21 January 2018

Identifiers

DOI

0 references

1 reference